BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29468855)

  • 1. Major clinical research advances in gynecologic cancer in 2017.
    Suh DH; Kim M; Lee KH; Eom KY; Kjeldsen MK; Mirza MR; Kim JW
    J Gynecol Oncol; 2018 Mar; 29(2):e31. PubMed ID: 29468855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major clinical research advances in gynecologic cancer in 2018.
    Kim M; Suh DH; Lee KH; Eom KY; Toftdahl NG; Mirza MR; Kim JW
    J Gynecol Oncol; 2019 Mar; 30(2):e18. PubMed ID: 30806045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major clinical research advances in gynecologic cancer in 2015.
    Suh DH; Kim M; Kim HJ; Lee KH; Kim JW
    J Gynecol Oncol; 2016 Nov; 27(6):e53. PubMed ID: 27775259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major clinical research advances in gynecologic cancer in 2014.
    Suh DH; Lee KH; Kim K; Kang S; Kim JW
    J Gynecol Oncol; 2015 Apr; 26(2):156-67. PubMed ID: 25872896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major clinical research advances in gynecologic cancer in 2013.
    Suh DH; Kim JW; Kang S; Kim HJ; Lee KH
    J Gynecol Oncol; 2014 Jul; 25(3):236-48. PubMed ID: 25045437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.
    Suh DH; Kim M; Kim K; Kim HJ; Lee KH; Kim JW
    J Gynecol Oncol; 2017 May; 28(3):e45. PubMed ID: 28382802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major clinical research advances in gynecologic cancer in 2019.
    Kim M; Suh DH; Lee KH; Eom KY; Lee JY; Lee YY; Hansen HF; Mirza MR; Kim JW
    J Gynecol Oncol; 2020 May; 31(3):e48. PubMed ID: 32319232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major clinical research advances in gynecologic cancer in 2021.
    Park JY; Lee JY; Lee YY; Shim SH; Suh DH; Kim JW
    J Gynecol Oncol; 2022 Mar; 33(2):e43. PubMed ID: 35245004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
    J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic-Based Therapy of Gynecologic Malignancies.
    Markman M
    Acta Med Acad; 2019 Apr; 48(1):84-89. PubMed ID: 31264436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major clinical research advances in gynecologic cancer in 2020.
    Lee YY; Choi MC; Park JY; Suh DH; Kim JW
    J Gynecol Oncol; 2021 Jul; 32(4):e53. PubMed ID: 34085794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.
    Liu FW; Tewari KS
    Curr Treat Options Oncol; 2016 Mar; 17(3):12. PubMed ID: 26931795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Systemic Treatment Landscape of Advanced Gynecologic Malignancies.
    Pan K; Gong J; Huynh K; Cristea M
    Target Oncol; 2019 Jun; 14(3):269-283. PubMed ID: 31069647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major clinical research advances in gynecologic cancer in 2012.
    Suh DH; Kim JW; Kim K; Kim HJ; Lee KH
    J Gynecol Oncol; 2013 Jan; 24(1):66-82. PubMed ID: 23346316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
    Masuda K; Hirasawa A; Irie-Kunitomi H; Akahane T; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Kataoka F; Tominaga E; Banno K; Susumu N; Aoki D
    Jpn J Clin Oncol; 2017 May; 47(5):401-406. PubMed ID: 28334914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.
    Parkes EE; Kennedy RD
    Oncologist; 2016 May; 21(5):586-93. PubMed ID: 27022037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abnormalities of DNA repair and gynecological cancers].
    Auguste A; Leary A
    Bull Cancer; 2017 Nov; 104(11):971-980. PubMed ID: 29054544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current recommendations and recent progress in endometrial cancer.
    Brooks RA; Fleming GF; Lastra RR; Lee NK; Moroney JW; Son CH; Tatebe K; Veneris JL
    CA Cancer J Clin; 2019 Jul; 69(4):258-279. PubMed ID: 31074865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.